Clinical Trial Update: BAL Fluid Biomarkers in Sarcoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical study evaluating biomarkers in bronchoalveolar lavage fluid for soft tissue sarcoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Snippet

Sponsor: University Health Network, Toronto | Conditions: Soft Tissue Sarcoma (STS), Bronchoalveolar Lavage (BAL) | Phase 2 | Status: RECRUITING